Clinical Trial Update: Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the neural processes and circuitry underlying threat sensitivity as a treatment target for co-morbid anxiety and depression…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Snippet

Sponsor: Laureate Institute for Brain Research, Inc. | Conditions: Depression, Anxiety, Fear | Phase 4 | Status: RECRUITING